XML 43 R33.htm IDEA: XBRL DOCUMENT v3.25.1
Financial Instruments (Schedule of Reconciliation of Contingent Consideration) (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Contingent Consideration    
Change in valuation $ 2,830 $ 17,470
Ascyrus Medical LLC    
Contingent Consideration    
Change in valuation (2,800) $ (17,500)
Ascyrus Medical LLC | Level 3    
Contingent Consideration    
Balance as of December 31, 2024 52,880  
Change in valuation (2,830)  
Balance as of March 31, 2025 $ 50,050